Here, we showed that treatment of AML cancer cells with FZD induced leukemic cell differentiation, evident by the increased expression of the myeloid differentiation marker CD11b, NBT reduction assay, as well as morphologic changes, specifically in Kasumi-1, carrying a t(8; 21) translocation [8]. This evidence concerns the gene ITGAM and cancer.